Why It Matters

The Food and Drug Administration (FDA) published draft guidance limiting cadmium, a toxic transition metal, in processed foods for babies and young children under two years old. ​

The proposal sets limits that vary by food type: 10 parts per billion (ppb) for most fruits, vegetables, and mixtures; 25 ppb for single-ingredient carrots and single-ingredient meats; 45 ppb for dry infant cereals; and 20 ppb for yogurts, puddings, and custards. The agency said the proposal advances its Closer to Zero initiative and considers levels achievable with manufacturer control measures.

The Broader Context

FDA drew on 1,430 samples collected from 2009 through 2024 to develop the proposed levels. The agency is also asking commenters to address costs or cost savings the guidance may generate, which it says is "relevant for Executive Order 14192," though the document names no title for that order.

The draft guidance "is intended to set achievable action levels that will help further reduce cadmium in the food supply," FDA said. The proposal covers processed foods sold for children under two but does not cover infant formula, beverages, raw agricultural commodities, homemade foods, or snack foods.

Single-ingredient carrots are carved out from the 10 ppb vegetable category and assigned their own 25 ppb action level in the draft guidance. Contemporary Pediatrics, citing FDA data, reported that the proposed levels are estimated to reduce modeled 90th-percentile cadmium exposure by 28 percent for fruits, vegetables, and mixtures and by 32 percent for carrots, but by only five percent for dry infant cereals.

No named outside groups have yet gone on record in opposition or support.

Advertisement

The Bottom Line

Within the document, FDA invited comments on whether there is "sufficient data or information" to support different levels for these categories of foods. Food Safety Magazine and The Daily Intake both noted that the action levels are not legally binding: FDA may consider them when evaluating whether a food is adulterated under the Federal Food, Drug, and Cosmetic Act, but exceeding a level does not automatically trigger enforcement.

The draft guidance does not amend the existing bill; it would operate under that existing action-level framework. The document contains no cost estimates and no count of affected manufacturers.

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article